In situ vascularization of injectable fibrin/poly(ethylene glycol) hydrogels by human amniotic fluid-derived stem cells

Simple item page
dc.citation.journalTitleJournal of Biomedical Materials Research Part A
dc.contributor.authorBenavides, Omar M.
dc.contributor.authorBrooks, Abigail R.
dc.contributor.authorCho, Sung Kyung
dc.contributor.authorConnell, Jennifer Petsche
dc.contributor.authorRuano, Rodrigo
dc.contributor.authorJacot, Jeffrey G.
dc.date.accessioned2015-02-27T21:50:06Z
dc.date.available2015-02-27T21:50:06Z
dc.date.issued2015
dc.description.abstractOne of the greatest challenges in regenerative medicine is generating clinically relevant engineered tissues with functional blood vessels. Vascularization is a key hurdle faced in designing tissue constructs larger than the in vivo limit of oxygen diffusion. In this study, we utilized fibrin-based hydrogels to serve as a foundation for vascular formation, poly(ethylene glycol) (PEG) to modify fibrinogen and increase scaffold longevity, and human amniotic fluid-derived stem cells (AFSC) as a source of vascular cell types (AFSC-EC). AFSC hold great potential for use in regenerative medicine strategies, especially those involving autologous congenital applications, and we have shown previously that AFSC-seeded fibrin-PEG hydrogels have the potential to form three-dimensional vascular-like networks in vitro. We hypothesized that subcutaneously injecting these hydrogels in immunodeficient mice would both induce a fibrin-driven angiogenic host response and promote in situ AFSC-derived neovascularization. Two weeks postinjection, hydrogels were sectioned, and the following was demonstrated: the average maximum invasion distance of host murine cells into the subcutaneous fibrin/PEG scaffold was 147 ± 90 µm after 1 week and 395 ± 138 µm after 2 weeks; the average number of cell-lined lumen per square millimeter was significantly higher in hydrogels seeded with stem cells or cocultures containing stem cells (MSC, 36.5 ± 11.4; AFSC, 47.0 ± 18.9; AFSC/AFSC-EC, 32.8 ± 11.6; and MSC/HUVEC, 43.1 ± 25.1) versus endothelial cell types alone (AFSC-EC, 9.7 ± 6.1; HUVEC, 14.2 ± 8.8); and a subset of these lumen were characterized by the presence of red blood cells. Select areas of cell-seeded hydrogels contained CD31+ lumen surrounded by α-smooth muscle cell support cells, whereas control hydrogels with no cells only showed infiltration of α-smooth muscle cell–positive host cells.
dc.identifier.citationBenavides, Omar M., Brooks, Abigail R., Cho, Sung Kyung, et al.. "In situ vascularization of injectable fibrin/poly(ethylene glycol) hydrogels by human amniotic fluid-derived stem cells." <i>Journal of Biomedical Materials Research Part A,</i> (2015) Wiley: http://dx.doi.org/10.1002/jbm.a.35402.
dc.identifier.doihttp://dx.doi.org/10.1002/jbm.a.35402
dc.identifier.urihttps://hdl.handle.net/1911/79045
dc.language.isoeng
dc.publisherWiley
dc.rightsThis is an author's peer-reviewed final manuscript, as accepted by the publisher. The published article is copyrighted by Wiley
dc.subject.keywordamniotic fluid-derived stem cells
dc.subject.keywordvasculogenesis
dc.subject.keywordhydrogels
dc.subject.keywordfibrin
dc.subject.keywordangiogenesis
dc.titleIn situ vascularization of injectable fibrin/poly(ethylene glycol) hydrogels by human amniotic fluid-derived stem cells
dc.typeJournal article
dc.type.dcmiText
dc.type.publicationpost-print
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Manuscript_for_Review.pdf
Size:
561.36 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Faculty Publications
Bioengineering Publications